Navamedic ASA (NAVA) - Net Assets

Latest as of December 2025: Nkr334.08 Million NOK ≈ $35.15 Million USD

Based on the latest financial reports, Navamedic ASA (NAVA) has net assets worth Nkr334.08 Million NOK (≈ $35.15 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr741.75 Million ≈ $78.05 Million USD) and total liabilities (Nkr407.67 Million ≈ $42.90 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check NAVA financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Nkr334.08 Million
% of Total Assets	45.04%
Annual Growth Rate	19.05%
5-Year Change	120.9%
10-Year Change	215.97%
Growth Volatility	48.07

Navamedic ASA - Net Assets Trend (2003–2025)

This chart illustrates how Navamedic ASA's net assets have evolved over time, based on quarterly financial data. Also explore NAVA asset base for the complete picture of this company's asset base.

Annual Net Assets for Navamedic ASA (2003–2025)

The table below shows the annual net assets of Navamedic ASA from 2003 to 2025. For live valuation and market cap data, see Navamedic ASA market cap and net worth.

Year	Net Assets	Change
2025-12-31	Nkr334.08 Million ≈ $35.15 Million	+38.95%
2024-12-31	Nkr240.44 Million ≈ $25.30 Million	+8.11%
2023-12-31	Nkr222.39 Million ≈ $23.40 Million	+6.04%
2022-12-31	Nkr209.72 Million ≈ $22.07 Million	+38.67%
2021-12-31	Nkr151.24 Million ≈ $15.91 Million	+16.80%
2020-12-31	Nkr129.49 Million ≈ $13.63 Million	+63.43%
2019-12-31	Nkr79.23 Million ≈ $8.34 Million	-20.23%
2018-12-31	Nkr99.32 Million ≈ $10.45 Million	+2.71%
2017-12-31	Nkr96.70 Million ≈ $10.18 Million	-8.54%
2016-12-31	Nkr105.73 Million ≈ $11.13 Million	-10.61%
2015-12-31	Nkr118.28 Million ≈ $12.45 Million	+6.34%
2014-12-31	Nkr111.23 Million ≈ $11.70 Million	+3.71%
2013-12-31	Nkr107.26 Million ≈ $11.29 Million	+10.95%
2012-12-31	Nkr96.68 Million ≈ $10.17 Million	+3.69%
2011-12-31	Nkr93.24 Million ≈ $9.81 Million	-6.95%
2010-12-31	Nkr100.21 Million ≈ $10.54 Million	-10.36%
2009-12-31	Nkr111.78 Million ≈ $11.76 Million	+1.40%
2008-12-31	Nkr110.24 Million ≈ $11.60 Million	-14.54%
2007-12-31	Nkr128.99 Million ≈ $13.57 Million	+111.93%
2006-12-31	Nkr60.87 Million ≈ $6.40 Million	+40.93%
2005-12-31	Nkr43.19 Million ≈ $4.54 Million	+126.94%
2004-12-31	Nkr19.03 Million ≈ $2.00 Million	+163.94%
2003-12-31	Nkr7.21 Million ≈ $758.70K	--

Equity Component Analysis

This analysis shows how different components contribute to Navamedic ASA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 71.8% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	Nkr1.88 Million	0.56%
Other Components	Nkr332.20 Million	99.44%
Total Equity	Nkr334.08 Million	100.00%

Navamedic ASA Competitors by Market Cap

The table below lists competitors of Navamedic ASA ranked by their market capitalization.

Company	Market Cap
Vection Technologies Ltd AU:VR1	$47.82 Million
Pan Brothers Tbk JK:PBRX	$47.83 Million
Fractal Gaming Group AB ST:FRACTL	$47.84 Million
Australian Vanadium Ltd AU:AVL	$47.85 Million
Union Corporation KO:000910	$47.82 Million
Mawana Sugars Limited NSE:MAWANASUG	$47.82 Million
Francotyp-Postalia Holding AG F:FPH	$47.81 Million
Victory Square Technologies Inc F:6F6	$47.76 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Navamedic ASA's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 240,437,000 to 334,077,000, a change of 93,640,000 (38.9%).
Net loss of 23,538,000 reduced equity.
New share issuances of 130,202,000 increased equity.
Other comprehensive income decreased equity by 1,000.
Other factors decreased equity by 13,023,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Nkr-23.54 Million	-7.05%
Share Issuances	Nkr130.20 Million	+38.97%
Other Comprehensive Income	Nkr-1.00K	-0.0%
Other Changes	Nkr-13.02 Million	-3.9%
Total Change	Nkr-	38.95%

Book Value vs Market Value Analysis

This analysis compares Navamedic ASA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.36x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 11.74x to 1.36x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2003-12-31	Nkr1.61	Nkr18.95	x
2004-12-31	Nkr4.26	Nkr18.95	x
2005-12-31	Nkr9.67	Nkr18.95	x
2006-12-31	Nkr10.70	Nkr18.95	x
2007-12-31	Nkr20.33	Nkr18.95	x
2008-12-31	Nkr14.60	Nkr18.95	x
2009-12-31	Nkr14.61	Nkr18.95	x
2010-12-31	Nkr13.27	Nkr18.95	x
2011-12-31	Nkr11.88	Nkr18.95	x
2012-12-31	Nkr11.54	Nkr18.95	x
2013-12-31	Nkr12.47	Nkr18.95	x
2014-12-31	Nkr12.98	Nkr18.95	x
2015-12-31	Nkr13.45	Nkr18.95	x
2016-12-31	Nkr10.27	Nkr18.95	x
2017-12-31	Nkr8.88	Nkr18.95	x
2018-12-31	Nkr9.13	Nkr18.95	x
2019-12-31	Nkr6.76	Nkr18.95	x
2020-12-31	Nkr8.95	Nkr18.95	x
2021-12-31	Nkr1.89	Nkr18.95	x
2022-12-31	Nkr12.32	Nkr18.95	x
2023-12-31	Nkr12.63	Nkr18.95	x
2024-12-31	Nkr13.61	Nkr18.95	x
2025-12-31	Nkr13.93	Nkr18.95	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Navamedic ASA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -7.05%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -4.16%
• Asset Turnover: 0.76x
• Equity Multiplier: 2.22x
Recent ROE (-7.05%) is below the historical average (-2.68%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2003	6.72%	556.84%	0.11x	0.11x	Nkr-236.55K
2004	27.76%	451.51%	0.07x	0.90x	Nkr3.38 Million
2005	-11.27%	-109.81%	0.09x	1.11x	Nkr-9.19 Million
2006	-12.44%	-1959.38%	0.01x	0.86x	Nkr-13.66 Million
2007	-2.49%	-10.09%	0.17x	1.44x	Nkr-16.11 Million
2008	-7.33%	-17.52%	0.29x	1.45x	Nkr-19.10 Million
2009	11.46%	24.37%	0.39x	1.22x	Nkr1.64 Million
2010	-11.16%	-20.31%	0.45x	1.23x	Nkr-21.21 Million
2011	-7.68%	-10.04%	0.51x	1.49x	Nkr-16.48 Million
2012	-3.37%	-3.67%	0.66x	1.38x	Nkr-12.92 Million
2013	-1.18%	-0.84%	0.85x	1.67x	Nkr-11.99 Million
2014	1.17%	0.59%	1.05x	1.92x	Nkr-9.82 Million
2015	-9.24%	-4.40%	0.90x	2.33x	Nkr-22.76 Million
2016	-10.08%	-3.89%	0.95x	2.72x	Nkr-21.23 Million
2017	-16.07%	-6.03%	1.04x	2.56x	Nkr-25.21 Million
2018	7.33%	3.96%	0.86x	2.16x	Nkr-2.65 Million
2019	-20.57%	-8.63%	1.01x	2.36x	Nkr-24.22 Million
2020	-12.71%	-7.84%	0.81x	2.01x	Nkr-29.41 Million
2021	0.41%	0.22%	0.84x	2.18x	Nkr-14.51 Million
2022	14.03%	7.70%	1.00x	1.83x	Nkr8.46 Million
2023	1.49%	0.65%	0.98x	2.36x	Nkr-18.94 Million
2024	0.54%	0.24%	1.08x	2.04x	Nkr-22.75 Million
2025	-7.05%	-4.16%	0.76x	2.22x	Nkr-56.95 Million

Industry Comparison

This section compares Navamedic ASA's net assets metrics with peer companies in the Medical Distribution industry.

No peer company data available for comparison.

About Navamedic ASA

OL:NAVA Norway Medical Distribution

Market Cap

$47.82 Million

Nkr454.45 Million NOK

Market Cap Rank

#22062 Global

#204 in Norway

Share Price

Nkr18.95

Change (1 day)

-0.26%

52-Week Range

Nkr18.95 - Nkr26.40

All Time High

Nkr42.60